课题基金 / 基金详情

Multidisciplinary Educational Approach to Reducing Cancer Disparities

Multidisciplinary Educational Approach to Reducing Cancer Disparities
减少癌症差异的多学科教育方法
批准号:
10246272
负责人:
Jorge Silvio Gutkind
金额:
$34.6万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2024-08-31
关键词:
AchievementAddressAdmission activityAwarenessBehavioralBiologicalBiomedical ResearchCaliforniaCancer BurdenCancer CenterCancer ControlCancer Control ResearchClinicalCollaborationsColorCommunitiesCommunity OutreachCountryCultural BackgroundsDatabasesDentistryDevelopmentDisciplineDiscipline of NursingDropsEducational BackgroundEducational StatusEducational workshopEngineeringEnrollmentEthnic groupEventExposure toGenderGeographyGoalsHealthHealth SciencesIndividualInstitutesInterdisciplinary StudyInterventionLaboratoriesLearningLiteratureMalignant NeoplasmsMedicalMedicineMentorsMolecular BiologyMonitorMorbidity - disease rateNCI-Designated Cancer CenterNanotechnologyNational Cancer InstituteOncologyParticipantPathway interactionsPharmacologyPlayPopulationPsychologyPublic HealthPublic SpeakingRaceResearchResearch ActivityResearch PersonnelResolutionReview LiteratureRoleSTEM programScheduleSchoolsScienceScience, Technology, Engineering and MathematicsSecureSex OrientationSolidStudent recruitmentStudentsSubgroupTimeTime ManagementTrainingUnderrepresented StudentsUnited StatesUnited States National Institutes of HealthUniversitiesWomanWorkWritingYouthacademic preparationage groupbasebiobehaviorcancer geneticscancer health disparitycareerclinical caredesigndrug discoveryeducation researchexperiencefaculty researchhands on researchhands-on learninghealth disparityinnovationlaboratory experiencelearning strategymeetingsmortalitymultidisciplinaryprogramsrecruitreligious groupscience educationskillssocioeconomic disadvantagesocioeconomicssuccesssymposiumtheoriestraining opportunitytranslational cancer researchtumor registryundergraduate student

项目摘要

项目成果

Jorge Silvio Gutkind的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 增加癌症研究人员和临床医生的多样性是寻找创新癌症的关键策略 控制解决方案和减少癌症差异。这个年轻人享受科学研究教育(是) 该计划将增加加州圣地亚哥大学(UCSD)毕业生的多样性, 科学方面的研究生/专业培训。这个YES计划是基于变革性学习 理论和UCSD的16年经验进行UCSD的成功治愈计划。这是YES 该计划将增加来自不同科学学科的女性和代表性不足的学生人数 谁准备研究生院录取,重点是解决癌症和癌症的差距。 具体来说,YES学生参加课堂和实验室学习活动,提高他们的 了解癌症以及国家和世界癌症的差异。因此,癌症的差异以及 它们被识别和解决成为连接这个YES计划的各种 学习活动。学生们从他们的角度出发,探讨与癌症差异相关的问题。 个人实验室培训、课程和讲习班、他们自己的文化背景、社区外展 他们部署的活动,以及他们选择的学术和专业途径。圣地亚哥的三个国家癌症研究所指定的 癌症中心(加州大学圣地亚哥分校、索尔克生物研究所和Sanford Burnham Prebys Medical Discovery 研究所)邀请YES学生在基础,行为,临床和转化癌症方面工作和学习 顶尖癌症研究人员的研究实验室在他们的实验室和教室里,YES学生获得了坚实的 了解癌症以及与癌症发展和恶化相关的许多生物行为问题, 癌症的差异和可能的解决方案。有了这些信息和他们的文献回顾,学生们学习 如何与多学科团队合作,制定帮助减少社区癌症的计划 发病率和死亡率。通过这些活动,学生们了解到,在他们的一生中,他们可以玩 在减少癌症差异方面发挥作用。为了帮助YES学生达到他们完整的学术,个人和 专业潜力,他们还提供补充学习经验,例如,公开演讲,目标 设置和时间管理,写作,进行文献检索和综合技能,和经验 介绍和讨论他们的研究工作与专业和外行观众。学生们还准备和 提交摘要,在研究研讨会和国家科学会议上介绍其研究成果。 YES计划学生的指导,继续在UCSD和研究生院的整个时间。 因此,这个YES计划的前提是,这个学习机会将给学生动手 研究经验和技能,这将有助于他们获得研究生水平的STEM课程录取, 癌症控制研究的职业生涯,始终专注于减少癌症差异。
英文摘要
PROJECT SUMMARY/ABSTRACT Increasing the diversity of cancer researchers and clinicians is a key strategy for finding innovative cancer control solutions and reducing cancer disparities. This Youth Enjoy Science Research Education (YES) Program will increase the diversity of University of California San Diego (UCSD) graduates who are pursuing graduate/professional training in the sciences. This YES Program is grounded on the Transformative Learning Theory and UCSD's 16 years of experience conducting UCSD's successful CURE Program. This YES Program will increase the number of women and underrepresented students from diverse scientific disciplines who are prepared for graduate school admission, with a focus on addressing cancer and cancer disparities. Specifically, YES students participate in classroom and laboratory learning activities that raise their understanding of cancer and the nation's and the world's cancer disparities. Thus, cancer disparities and how they are identified and resolved become the common theme that interconnects this YES Program's various learning activities. Students approach the issues related to cancer disparities, from the perspective of their individual laboratory training, classes and workshops, their own cultural backgrounds, community outreach events they deploy, and their chosen academic and professional pathways. San Diego's three NCI-designated cancer centers (UCSD, Salk Institute for Biological Studies, and Sanford Burnham Prebys Medical Discovery Institute) invite the YES students to work and learn in the basic, behavioral, clinical and translational cancer research labs of their top cancer researchers. In their labs and classrooms, the YES students gain a solid understanding of cancer and the many bio-behavioral issues related to the development and exacerbation of cancer disparities and the possible resolutions. With this information and their literature review, students learn how to work on multidisciplinary teams as they develop programs to help reduce their community's cancer morbidity and mortality rates. Through these activities, students learn that, throughout their lives, they can play a role in reducing cancer disparities. To help YES students' reach their full academic, personal, and professional potential, they are also offered supplementary learning experiences, e.g., public speaking, goal setting and time management, writing, conducting literature search and synthesis skills, and experiences presenting and discussing their research work with professional and lay audiences. Students also prepare and submit abstracts to present their research findings at research symposia and national scientific meetings. Mentoring of the YES Program students, continues throughout their time at UCSD and on to graduate school. Thus, the premise of this YES program is that this learning opportunity will give the students hands-on research experiences and skills that will help them to secure admission to graduate level STEM programs and careers in cancer control research, always with a focus on reducing cancer disparities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signal Transduction by PI3K/mTOR
Signal Transduction by PI3K/mTOR
Signal Transduction by PI3K/mTOR
Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
海外基金